SEC Form 4 · accession 0001209191-18-031614
REVA Medical, Inc. · RVA:AX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Regina E Groves
Officer — Chief Executive Officer · Director
Period of report
May 16, 2018
Accepted (ET)
May 18, 2018 · 9:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001496268
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock (RSUs)F1 | May 16, 2018 | A | 114,000 | $0.00 | A | 236,109 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2 | $1.96 | May 16, 2018 | A | 226,000 | A | — | May 16, 2028 | Common Stock | 226,000 | 226,000 | D |
Explanation of responses
- F1The restricted stock units (RSUs) convert into shares of Common Stock on a one-for-one basis. The RSUs vest in three (3) equal annual installments beginning on May 16, 2019.
- F2The option vests and becomes exercisable as follows: 25% of the shares vest on May 16, 2019 with the remaining shares vesting at the rate of 2.0833% per month thereafter until fully vested.